Allan Bayat

Allan Bayat is a Clinical Associate Professor and Honorary Senior Research Fellow at the University of Bristol's Department of Regional Health Research. He also serves at IRS - The Epilepsyhospital Filadelfia in Denmark as part of the Research Unit of Epilepsy Genetics and Personalized Medicine (Dianalund). As a pediatric neurologist and translational researcher with a PhD, Dr. Bayat focuses on rare genetic neurological disorders and epilepsy research.

His educational background includes:

• MD in Pediatric Neurology
• PhD

Dr. Bayat's research centers on rare monogenic neurodevelopmental disorders and epilepsy, with specific aims to deep phenotype these disorders, identify genotype-phenotype correlations, discover clinical biomarkers, explore natural disease progression, and develop precision therapies based on genetic diagnoses. His work emphasizes N-of-1 clinical drug trials with personalized medicine approaches. His research spans neurology, genetics, and personalized treatment strategies for rare neurological conditions.

Analysis of Dr. Bayat's recent publications reveals a strong focus on genetic epilepsy syndromes, neurodevelopmental disorders, and precision medicine approaches. His work frequently examines genotype-phenotype correlations in conditions like Aarskog-Scott syndrome, KCNQ2/3 channelopathies, GRIA2/GRIA3 variants, SYN1-related epilepsy, and Shprintzen-Goldberg syndrome. The research integrates clinical phenotyping with genetic analysis to advance personalized treatment approaches.

Dr. Bayat has secured significant research funding, including:

• 2.2 million kr grant for research on rare genetic errors
• Million grant for cerebral palsy research
• Million donation to the epilepsy hospital
• 2 million kr for genetics research at Filadelfia

As a translational researcher, Dr. Bayat bridges clinical practice and genetic research, focusing on how genetic findings can directly inform patient care. His work involves multidisciplinary collaborations across institutions to advance understanding and treatment of rare neurological conditions. The research unit he's part of at Filadelfia appears to be a specialized center for epilepsy genetics and personalized medicine approaches.